Abbott Labs (ABT) PT Lowered to $121 at Goldman Sachs
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $101.95 -1.36%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Goldman Sachs analyst David Roman lowered the price target on Abbott Labs (NYSE: ABT) to $121.00 (from $140.00) while maintaining a Conviction Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
- Adobe (ADBE) PT Raised to $255 at UBS Following Q3 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
